Anton RF, O’Malley SS, Ciraulo DA, et al: Combined pharmacotherapies and behavioral interventions for alcohol dependence. JAMA 295:2003, 2006.
Baghurst PA, McMichael AJ, Wigg NR, et al: Environmental exposure to lead and children’s intelligence at the age of seven years—the Port Pirie Cohort Study. N Engl J Med 327:1279, 1992.
Baldessarini RJ: Drugs and the treatment of psychiatric disorders: Depression and mania. In: Hardman JG, Limbrin LE,
Gilman GA, et al (eds): Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 10th ed. New York, McGraw-Hill, 2001, pp 485–520.
Baldessarini RJ: Drugs and the treatment of psychiatric disorders: Psychosis and anxiety. In: Hardman JG, Limbrin LE,
Molinoff PB, et al (eds): Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York, McGraw-Hill, 1996, pp 399–430.
Baldessarini RJ: Drugs and the treatment of psychiatric disorders: Psychosis and anxiety. In: Hardman JG, Limbrin LE,
Gilman AG, et al (eds): Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 10th ed. New York, McGraw-Hill, 2001, pp 447–484.
Bank WJ, Pleasure DE, Suzuki D, et al: Thallium poisoning. Arch Neurol 26:456, 1972.
Baud FJ, Galliot M, Astier A, et al: Treatment of ethylene glycol poisoning with intravenous 4-methylpyrazole. N Engl J Med 319:97, 1988.
Bohman M: Some genetic aspects of alcoholism and criminality. Arch Gen Psychiatry 35:269, 1978.
Boyer EW: Management of opioid analgesic overdose. N Engl J Med 367:2, 2012.
Boyer EW, Shannon M: The serotonin syndrome. N Engl J Med 352:1112, 2005.
Boyer LV, Theodorous AA, Berg, RA, et al: Antivenom for critically ill children with neurotoxicity from scorpion stings. N Engl J Med 360:2090, 2009.
Brent JB: Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med 360:2216, 2009.
Brent J, McMartin K, Phillips S, et al: Fomepizole for the treatment of ethylene glycol poisoning. N Engl J Med 340:832, 1999.
Brewer C, Perrett L: Brain damage due to alcohol consumption: An air-encephalographic, psychometric and electroencephalographic study. Br J Addict 66(3):170, 1971.
Buge A, Supino-Viterbo V, Rancurel G, Pontes C: Epileptic phenomena in bismuth toxic encephalopathy. J Neurol Neurosurg Psychiatry 44:62, 1981.
Burger PC, Kamenar E, Schold SC, et al: Encephalomyelopathy following high-dose BCNU therapy. Cancer 48:1318, 1981.
Burns R, Thomas DQ, Barron VJ: Reversible encephalopathy possibly associated with bismuth subgallate ingestion. Br Med J 1:220, 1974.